Berenice Mejía-Aguirre, Ana Karen Luna-Vargas, Gamaliel Benítez-Arvizu
{"title":"[献血者及其成分中感染因子的血清阳性率]。","authors":"Berenice Mejía-Aguirre, Ana Karen Luna-Vargas, Gamaliel Benítez-Arvizu","doi":"10.5281/zenodo.14616969","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The seroprevalence of infectious agents in donors of blood and blood components is a relevant factor related to the biosecurity of blood components, therefore, the adequate choice of laboratory methods for screening, confirmatory and/or supplementary tests with high sensitivity and specificity.</p><p><strong>Objective: </strong>To estimate the seroprevalence of infectious agents transmitted by blood transfusion in blood donors during the period 2020 to 2023 at the CMN Siglo XXI Blood Bank.</p><p><strong>Material and methods: </strong>Descriptive, observational, retrospective study in 180,120 eligible blood donors and their components from the CMN Siglo XXI Blood Bank, between 18 and 65 years of age with reactive serology, during the period 2020-2023. The reactive serological markers of donors registered in the TESI-HEXABANK system and confirmatory/supplementary tests were analyzed. For the univariate analysis, Excel and SPSS version 26 were used.</p><p><strong>Results: </strong>The present study estimated that the seroprevalence of infectious agents transmitted by transfusion from 2020 to 2023 was 1.38% (n = 2489). The most seroprevalent marker was Treponema pallidum at 0.64%, followed by hepatitis C virus at 0.27%, human immunodeficiency virus at 0.19%, Trypanosoma cruzi at 0.15% and hepatitis B virus at 0.09%.</p><p><strong>Conclusions: </strong>The seroprevalence of transfusion-transmitted infectious agents allows us to visualize the regional epidemiological panorama of blood donors, which will generate new strategies for transfusion safety in recipients.</p>","PeriodicalId":94200,"journal":{"name":"Revista medica del Instituto Mexicano del Seguro Social","volume":"63 2","pages":"e6588"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12043350/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Seroprevalence of infectious agents in blood donors and their components].\",\"authors\":\"Berenice Mejía-Aguirre, Ana Karen Luna-Vargas, Gamaliel Benítez-Arvizu\",\"doi\":\"10.5281/zenodo.14616969\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The seroprevalence of infectious agents in donors of blood and blood components is a relevant factor related to the biosecurity of blood components, therefore, the adequate choice of laboratory methods for screening, confirmatory and/or supplementary tests with high sensitivity and specificity.</p><p><strong>Objective: </strong>To estimate the seroprevalence of infectious agents transmitted by blood transfusion in blood donors during the period 2020 to 2023 at the CMN Siglo XXI Blood Bank.</p><p><strong>Material and methods: </strong>Descriptive, observational, retrospective study in 180,120 eligible blood donors and their components from the CMN Siglo XXI Blood Bank, between 18 and 65 years of age with reactive serology, during the period 2020-2023. The reactive serological markers of donors registered in the TESI-HEXABANK system and confirmatory/supplementary tests were analyzed. For the univariate analysis, Excel and SPSS version 26 were used.</p><p><strong>Results: </strong>The present study estimated that the seroprevalence of infectious agents transmitted by transfusion from 2020 to 2023 was 1.38% (n = 2489). The most seroprevalent marker was Treponema pallidum at 0.64%, followed by hepatitis C virus at 0.27%, human immunodeficiency virus at 0.19%, Trypanosoma cruzi at 0.15% and hepatitis B virus at 0.09%.</p><p><strong>Conclusions: </strong>The seroprevalence of transfusion-transmitted infectious agents allows us to visualize the regional epidemiological panorama of blood donors, which will generate new strategies for transfusion safety in recipients.</p>\",\"PeriodicalId\":94200,\"journal\":{\"name\":\"Revista medica del Instituto Mexicano del Seguro Social\",\"volume\":\"63 2\",\"pages\":\"e6588\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12043350/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista medica del Instituto Mexicano del Seguro Social\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5281/zenodo.14616969\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica del Instituto Mexicano del Seguro Social","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5281/zenodo.14616969","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:血液和血液成分献血者中感染性病原体的血清流行率是与血液成分生物安全相关的一个因素,因此,充分选择实验室方法进行筛选、高灵敏度和特异性的确认和/或补充试验。目的:了解2020 - 2023年西格洛21世纪血库献血者输血传播感染因子的血清阳性率。材料和方法:描述性、观察性、回顾性研究,在2020-2023年期间,来自CMN Siglo XXI血库的180,120名符合条件的献血者及其组成部分,年龄在18至65岁之间,血清学反应性。分析在TESI-HEXABANK系统中登记的献血者的反应性血清学标志物和确认/补充试验。单因素分析采用Excel和SPSS version 26。结果:本研究估计2020 - 2023年输血传播感染因子的血清阳性率为1.38% (n = 2489)。梅毒螺旋体(0.64%)、丙型肝炎病毒(0.27%)、人类免疫缺陷病毒(0.19%)、克氏锥虫(0.15%)和乙型肝炎病毒(0.09%)的血清流行率最高。结论:输血传播感染因子的血清流行率使我们能够可视化献血者的区域流行病学全景,这将为接受者的输血安全提供新的策略。
[Seroprevalence of infectious agents in blood donors and their components].
Background: The seroprevalence of infectious agents in donors of blood and blood components is a relevant factor related to the biosecurity of blood components, therefore, the adequate choice of laboratory methods for screening, confirmatory and/or supplementary tests with high sensitivity and specificity.
Objective: To estimate the seroprevalence of infectious agents transmitted by blood transfusion in blood donors during the period 2020 to 2023 at the CMN Siglo XXI Blood Bank.
Material and methods: Descriptive, observational, retrospective study in 180,120 eligible blood donors and their components from the CMN Siglo XXI Blood Bank, between 18 and 65 years of age with reactive serology, during the period 2020-2023. The reactive serological markers of donors registered in the TESI-HEXABANK system and confirmatory/supplementary tests were analyzed. For the univariate analysis, Excel and SPSS version 26 were used.
Results: The present study estimated that the seroprevalence of infectious agents transmitted by transfusion from 2020 to 2023 was 1.38% (n = 2489). The most seroprevalent marker was Treponema pallidum at 0.64%, followed by hepatitis C virus at 0.27%, human immunodeficiency virus at 0.19%, Trypanosoma cruzi at 0.15% and hepatitis B virus at 0.09%.
Conclusions: The seroprevalence of transfusion-transmitted infectious agents allows us to visualize the regional epidemiological panorama of blood donors, which will generate new strategies for transfusion safety in recipients.